This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Alberta directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $1,269,900
Peripheral Co-Activation of Orexin and GLP-1 Receptors for Obesity Treatment with Muscle Preservation
CIHR · 2026 · Nominated PI
Peripheral Co-Activation of Orexin and GLP-1 Receptors for Obesity Treatment with Muscle Preservation
Principal investigators: Tabatabaei Dakhili, Seyed Amirhossein
Keywords: Drug Discovery; Drug Discovery And Development; Glp1 Receptor Agonist; Obesity; Orexins; Peptide Therapeutics
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.